Broadly neutralizing antibodies that target hiv env v3 n-glycans
US-2025320280-A1 · Oct 16, 2025 · US
This patent family groups 10 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 50488789 |
| Family type | — |
| Earliest priority | Oct 18, 2012 |
| First filing country | US |
| Member publications | 10 |
| Countries | US |
| Representative publication | US2025320280A1 — Broadly neutralizing antibodies that target hiv env v3 n-glycans |
Best representative member for this family based on priority and filing country.
US2025320280A1 — Broadly neutralizing antibodies that target hiv env v3 n-glycans (published Oct 16, 2025)
Related publications in this family.
US-2025320280-A1 · Oct 16, 2025 · US
US-12338277-B2 · Jun 24, 2025 · US
US-2023279082-A1 · Sep 7, 2023 · US
US-11649276-B2 · May 16, 2023 · US
US-2022002390-A1 · Jan 6, 2022 · US
US-11142564-B2 · Oct 12, 2021 · US
US-2019345233-A1 · Nov 14, 2019 · US
US-10392433-B2 · Aug 27, 2019 · US
US-10047146-B2 · Aug 14, 2018 · US
US-2015274813-A1 · Oct 1, 2015 · US